Gene expression in human NAFLD.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Physiology - Gastrointestinal and Liver Physiology

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpgi.00074.2008PMID 18388185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism

  2010cited by this paper
• Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.

  2007cited by this paper
• Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

  2007cited by this paper
• Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

  2007influential reference
• Fatty Liver: A Novel Component of the Metabolic Syndrome

  2007cited by this paper
• BMC Bioinformatics BioMed Central Correspondence

  2007cited by this paper
• Lipid mediators of insulin resistance.

  2007cited by this paper
• Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

  2007influential reference
• Identification of a gene-pathway associated with non-alcoholic steatohepatitis.

  2007cited by this paper
• Liver fat in the metabolic syndrome.

  2007influential reference
• The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists

  2007cited by this paper
• Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity

  2007cited by this paper
• Lipid metabolism in the liver.

  2007influential reference
• Gene Expression Patterns in Hepatic Tissue and Visceral Adipose Tissue of Patients with Non-Alcoholic Fatty Liver Disease

  2007cited by this paper
• Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray

  2006influential reference
• Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise

  2006cited by this paper
• Overproduction of large VLDL particles is driven by increased liver fat content in man

  2006influential reference
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.

  2006cited by this paper
• Ceramides in insulin resistance and lipotoxicity.

  2006cited by this paper
• Role of macrophage tissue infiltration in metabolic diseases

  2005influential reference
• Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

  2005influential reference
• Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

  2005cited by this paper
• Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

  2005cited by this paper
• A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

  2005influential reference
• Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.

  2005influential reference
• The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

  2005influential reference
• Dietary fat content modifies liver fat in overweight nondiabetic subjects.

  2005cited by this paper
• Hepatic gene expression in patients with obesity‐related non‐alcoholic steatohepatitis

  2005influential reference
• Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

  2005cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource

  2004cited by this paper
• The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis.

  2004cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003influential reference
• Monocyte chemoattractant protein 1 in obesity and insulin resistance

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003influential reference
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cited by this paper
• Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

  2003cited by this paper
• The KEGG database.

  2002cited by this paper
• Hepatic lipase: a pro- or anti-atherogenic protein?

  2002cited by this paper
• Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

  2002cited by this paper
• Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance*

  2002cited by this paper
• Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

  2001cited by this paper
• Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

  2001cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

  2000cited by this paper
• Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.

  1999cited by this paper
• On the Control of Lipolysis in Adipocytes

  1999cited by this paper
• A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women.

  1999cited by this paper
• Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

  1999cited by this paper
• Liver Steatosis and Its Relation to Plasma Haemostatic Factors in Apparently Healthy Men - Role of the Metabolic Syndrome

  1996cited by this paper
• Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.

  1996cited by this paper
• Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

  1996influential reference
• 73. Liver steatosis and its relation to haemostatic factors in healthy males

  1996cited by this paper
• Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene*

  1996cited by this paper
• Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun

  1994cited by this paper
• Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels.

  1991cited by this paper
• Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.

  1989influential reference
• Molecular cloning of cDNAs encoding rat and human medium-chain acyl-CoA dehydrogenase and assignment of the gene to human chromosome 1.

  1986cited by this paper

• CD36 in liver diseases

  2025cites this paper
• Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH.

  2025cites this paper
• Associations between circulating amino acids and hepatic steatosis indices in Iranian adults aged over 50: findings from the Bushehr elderly health (BEH) program

  2025cites this paper
• Diesel exhaust induces hepatic steatosis by activating the aryl hydrocarbon receptor/CD36 pathway.

  2025cites this paper
• Poria cocos Polysaccharide Delays Aging by Enhancing the Antioxidant Ability and Suppressing the Expression of the Branched-Chain Amino Acid Transferase-Encoding Gene in Drosophila melanogaster.

  2025cites this paper
• The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation

  2025cites this paper
• Polymer-lipid hybrid nanoparticles incorporating green coffee extract: enhancing treatment for hepatic steatosis and fibrosis through metabolomic insights

  2025cites this paper
• YBX1/CD36 positive feedback loop-mediated lipid accumulation drives metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• β-Carotene-loaded cationic nanoparticles ameliorate MASLD via modulating lipid homeostasis and gut microbiome.

  2025cites this paper
• Decoding the CD36-Centric Axis in Gastric Cancer: Insights into Lipid Metabolism, Obesity, and Hypercholesterolemia

  2025cites this paper
• Exploring the mechanism of PFTrDA on human hepatic metabolic diseases based on network toxicology and molecular docking

  2025cites this paper
• Piperidinesulfonyl derivatives, novel CYP4A inhibitors, ameliorate hepatic lipotoxicity in metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis.

  2025cites this paper
• Skeletal Muscle and Cardiovascular Health.

  2025cites this paper
• Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression

  2025cites this paper
• Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease

  2025cites this paper
• Long-term supplementation of taurine induces hepatic steatosis and disrupts bile acid homeostasis in male mice.

  2025cites this paper
• Chronic Nanoplastic Exposure Promotes the Development and Progression of Metabolic Dysfunction‐Associated Steatotic Liver Disease

  2025cites this paper
• Endoplasmic Reticulum Stress Modulates Therapeutic Responses in Hepatocellular Carcinoma

  2025cites this paper
• A Review on Branched-Chain Amino Acid Aminotransferase (BCAT) Inhibitors: Current Status, Challenges and Perspectives.

  2025cites this paper
• Transcriptional Factors of FAT/CD36, PTP1B, SREBP-1c and HNF4A Are Involved in Dyslipidemia Following Cyclosporine a Treatment in the Liver of Rats: The Rescue Effect of Curcumin.

  2025cites this paper
• Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.

  2024cites this paper
• Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma

  2024cites this paper
• Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis

  2024cites this paper
• Sex-specific expression of the human NAFLD-NASH transcriptional signatures in the liver of medaka with a history of ancestral bisphenol A exposure

  2024cites this paper
• Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review

  2024cites this paper
• Luteolin Ameliorates Non-alcoholic Fatty Liver Disease via Regulation of Hepatic Lipid Uptake, Autophagy, and Apoptosis in WD/CCl4-induced Mice

  2024cites this paper
• Exploring the impacts of ketogenic diet on reversible hepatic steatosis: initial analysis in male mice

  2024cites this paper
• Terf2ip deficiency accelerate non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/ AMPK pathway.

  2024cites this paper
• Molecular mechanism and therapeutic significance of essential amino acids in metabolically associated fatty liver disease.

  2024cites this paper
• Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte Culture

  2024cites this paper
• Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease

  2024cites this paper
• Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats.

  2024cites this paper
• TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner

  2024cites this paper
• Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment.

  2024cites this paper
• PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways

  2024cites this paper
• Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression.

  2024cites this paper
• Medaka liver developed Human NAFLD-NASH transcriptional signatures in response to ancestral bisphenol A exposure

  2024cites this paper
• Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome

  2023cites this paper
• Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Insights into the development of insulin resistance: Unraveling the interaction of physical inactivity, lipid metabolism and mitochondrial biology

  2023cites this paper
• Dendritic cell–intrinsic LKB1-AMPK/SIK signaling controls metabolic homeostasis by limiting the hepatic Th17 response during obesity

  2023cites this paper
• High fat diet and PCSK9 knockout modulates lipid profile of the liver and changes the expression of lipid homeostasis related genes

  2023influential citation
• Involvement of glyphosate in disruption of biotransformation P450 enzymes and hepatic lipid metabolism in chicken

  2023cites this paper
• Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults

  2023cites this paper
• Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Positive allosteric GABAA receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes in vitro

  2023cites this paper
• A Metabolomics-Based Investigation of the Effects of a Short-Term Body Weight Reduction Program in a Cohort of Adolescents with Obesity: A Prospective Interventional Clinical Study

  2023cites this paper
• Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease.

  2023cites this paper
• Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge

  2023cites this paper
• Hepatic and serum branched‐chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case–control study

  2023cites this paper
• Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)

  2023cites this paper
• Investigating dual inhibition of ACC and CD36 for the treatment of non-alcoholic fatty liver disease in mice.

  2023cites this paper
• Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease

  2023cites this paper
• Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease

  2023cites this paper
• FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression.

  2023cites this paper
• Inhibition of cluster antigen 36 protects against fatty acids-induced lipid accumulation, oxidative stress, and inflammation in bovine hepatocytes.

  2023cites this paper
• Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway

  2023cites this paper
• Early-life stress perturbs the epigenetics of Cd36 concurrent with adult onset of NAFLD in mice

  2023cites this paper
• Basal MET Phosphorylation is an Indicator of Hepatocyte Dysregulation in Liver Disease

  2023cites this paper
• Non-Alcoholic Fatty Liver Disease (NAFLD): Molecular Mechanism, Pathological Progression and Treatment

  2023cites this paper
• Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis

  2023cites this paper
• Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease

  2023cites this paper
• Ceramide concentrations in liver, plasma, and very low-density lipoproteins of humans with severe obesity.

  2023cites this paper
• role of chemokines in liver disease

  2022cites this paper
• Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes

  2022cites this paper
• Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases

  2022influential citation
• LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206/ARNT Axis

  2022cites this paper
• An Update on the Chemokine System in the Development of NAFLD

  2022cites this paper
• Single-cell metabolic profiling reveals subgroups of primary human hepatocytes showing heterogeneous responses to drug challenge

  2022cites this paper
• Effects of chemical mixtures on liver function biomarkers in the Korean adult population: thresholds and molecular mechanisms for non-alcoholic fatty liver disease involved

  2022cites this paper
• NAFLD: Mechanisms, Treatments, and Biomarkers

  2022cites this paper
• Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH

  2022cites this paper
• A biologically based model to quantitatively assess the role of the nuclear receptors liver X (LXR), and pregnane X (PXR) on chemically induced hepatic steatosis.

  2022cites this paper
• SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection

  2022cites this paper
• Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease

  2022cites this paper
• B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36

  2022cites this paper
• Autophagy in the liver

  2022cites this paper
• Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor

  2022influential citation
• Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease

  2022cites this paper
• Hepatic Transporters Alternations Associated with Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Review

  2022cites this paper
• Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver

  2022cites this paper
• Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms.

  2022cites this paper
• Hepatic PGC-1α has minor regulatory effect on the transcriptome and metabolome during high fat high fructose diet and exercise.

  2022cites this paper
• Ficus hirta Vahl. Ameliorates Nonalcoholic Fatty Liver Disease through Regulating Lipid Metabolism and Gut Microbiota

  2022cites this paper
• CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice

  2022cites this paper
• CD36 favours fat sensing and transport to govern lipid metabolism.

  2022cites this paper
• Hepatic PGC-1 has minor regulatory effect on the liver transcriptome and metabolome during high fat high fructose diet and exercise training

  2022cites this paper
• An overview of branched-chain amino acid aminotransferases: functional differences between mitochondrial and cytosolic isozymes in yeast and human

  2021cites this paper
• Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH

  2021cites this paper
• Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology

  2021cites this paper
• Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice

  2021cites this paper
• GADD45β stabilized by direct interaction with HSP72 ameliorates insulin resistance and lipid accumulation.

  2021cites this paper
• MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice

  2021cites this paper
• Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring

  2021cites this paper
• Modulation of endothelium function by fatty acids

  2021cites this paper
• Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway.

  2021cites this paper
• Role of Insulin Resistance in MAFLD

  2021cites this paper
• Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship

  2021cites this paper